ArticleBMC research notes2025
Paradigm shift in age of multiple myeloma patients: a study from a tertiary care government oncology hospital in Pakistan.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMultiple myeloma is a hematological disorder characterized by the presence of clonal plasma cells in the bone marrow that produce anemia, bone lesions, and kidney disease. The aim of this study was to determine the clinicopathological profile including age, sex, common symptoms and stage of patients with multiple myeloma diagnosed and managed in a government sector hospital in Pakistan. PATIENTS AND
methodsThis retrospective cross-sectional study was conducted over a period of eight years at the Institute of Nuclear Medicine, Oncology, and Radiotherapy in Islamabad. Of the 89 patients diagnosed and treated in this hospital, 81 patients with complete data were included in the study.
resultsOf the 81 patients, 55 were males and 27 were female patients. The mean age at diagnosis in our set of patients was 53 years, with 79% of the patients aged ≤ 60 years of age. The most common presenting symptom was bone pain followed by generalized fatigue and infections. The most common monoclonal gammopathy was IgG;12.3% patients were in stage I, 48.1% in stage II and 39.5% in stage III.
conclusionsOur study revealed that the patients in our institution presented multiple myeloma at much younger age than the patients seen in developed countries of the world. Most studies from Pakistan present data from private sector hospitals. This is the first study conducted at a Pakistani government hospital in patients with multiple myeloma. More studies should be conducted representing patients from both private and government hospitals to understand the true magnitude of the disease and the factors behind this age difference in patients with multiple myeloma in our part of the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.